Renalytix Correlations

RNLX Stock

USD 0.15 0.00 0.00%

The current 90-days correlation between Renalytix AI and Streamline Health Solutions is -0.05 (i.e., Good diversification). The correlation of Renalytix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Renalytix Correlation With Market

Significant diversification

The correlation between Renalytix AI and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Renalytix AI and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Moving together with Renalytix Stock

0.65	TFX	Teleflex Incorporated	Pair Corr
0.69	VRAX	Virax Biolabs Group	Pair Corr
0.81	VRCA	Verrica Pharmaceuticals	Pair Corr
0.66	VRPX	Virpax Pharmaceuticals	Pair Corr
0.8	FATE	Fate Therapeutics	Pair Corr
0.66	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.84	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr

Moving against Renalytix Stock

0.92	VMD	Viemed Healthcare	Pair Corr
0.9	EWTX	Edgewise Therapeutics	Pair Corr
0.84	VRNA	Verona Pharma PLC	Pair Corr
0.83	ETON	Eton Pharmaceuticals	Pair Corr
0.79	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.78	BSX	Boston Scientific Corp	Pair Corr
0.64	ELDN	Eledon Pharmaceuticals Downward Rally	Pair Corr
0.53	IVA	Inventiva Sa	Pair Corr
0.5	ABT	Abbott Laboratories Fiscal Year End 22nd of January 2025	Pair Corr
0.47	DXCM	DexCom Inc	Pair Corr
0.45	HCM	HUTCHMED DRC	Pair Corr
0.37	SYK	Stryker	Pair Corr
0.35	DSGN	Design Therapeutics	Pair Corr
0.79	GILD	Gilead Sciences	Pair Corr
0.71	OCUL	Ocular Therapeutix	Pair Corr
0.7	LPCN	Lipocine Downward Rally	Pair Corr
0.69	MLYS	Mineralys Therapeutics,	Pair Corr
0.61	LUMO	Lumos Pharma	Pair Corr
0.48	PLX	Protalix Biotherapeutics	Pair Corr
0.48	JANX	Janux Therapeutics	Pair Corr
0.42	MIST	Milestone Pharmaceuticals	Pair Corr

Related Correlations Analysis

	STRM	HSTM	NRC	CPSI	NXGN	FORA	TRHC	ACONW	MGRX	SNCE
STRM		-0.24	0.57	0.75	0.72	0.8	-0.42	0.04	0.61	0.62	STRM
HSTM	-0.24		-0.25	-0.1	-0.02	-0.52	0.84	-0.07	-0.55	-0.57	HSTM
NRC	0.57	-0.25		0.28	0.49	0.67	-0.55	-0.12	0.79	0.42	NRC
CPSI	0.75	-0.1	0.28		0.71	0.61	-0.24	0.2	0.29	0.59	CPSI
NXGN	0.72	-0.02	0.49	0.71		0.61	-0.1	0.08	0.35	0.47	NXGN
FORA	0.8	-0.52	0.67	0.61	0.61		-0.75	-0.03	0.79	0.71	FORA
TRHC	-0.42	0.84	-0.55	-0.24	-0.1	-0.75		0.08	-0.78	-0.61	TRHC
ACONW	0.04	-0.07	-0.12	0.2	0.08	-0.03	0.08		-0.07	0.18	ACONW
MGRX	0.61	-0.55	0.79	0.29	0.35	0.79	-0.78	-0.07		0.6	MGRX
SNCE	0.62	-0.57	0.42	0.59	0.47	0.71	-0.61	0.18	0.6		SNCE
	STRM	HSTM	NRC	CPSI	NXGN	FORA	TRHC	ACONW	MGRX	SNCE

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TRHC	+ 0.84	HSTM
FORA	+ 0.8	STRM
MGRX	+ 0.79	NRC
MGRX	+ 0.79	FORA
CPSI	+ 0.75	STRM
NXGN	+ 0.72	STRM

High negative correlations

MGRX	- 0.78	TRHC
TRHC	- 0.75	FORA
SNCE	- 0.61	TRHC
SNCE	- 0.57	HSTM
TRHC	- 0.55	NRC
MGRX	- 0.55	HSTM

Risk-Adjusted Indicators

There is a big difference between Renalytix Stock performing well and Renalytix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Renalytix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
STRM	7.12	(1.11)	0.00	(0.94)	0.00	0.00	19.40	(14.33)	55.52
HSTM	1.20	0.11	0.07	0.23	1.29	(1.28)	2.33	(2.00)	10.49
NRC	1.97	(0.35)	0.00	(0.09)	0.00	0.00	3.79	(4.72)	13.17
CPSI	1.50	(0.16)	0.00	5.70	0.00	0.00	2.85	(3.01)	14.25
NXGN	1.10	(0.14)	0.00	(0.38)	0.00	0.00	2.81	(2.35)	7.28
FORA	1.28	(0.17)	0.00	0.79	0.00	0.00	2.82	(2.38)	9.93
TRHC	2.76	0.67	0.19	1.75	2.59	(3.14)	7.81	(4.61)	14.89
ACONW	6.65	1.05	0.11	0.81	6.50	(15.78)	28.38	(15.28)	58.58
MGRX	4.22	(0.18)	0.00	1.56	0.00	0.00	7.29	(7.65)	37.65
SNCE	5.28	0.29	0.00	0.01	0.00	0.00	11.11	(10.00)	29.72

Renalytix Corporate Management

Oliver III	Chief Officer	Profile
Jean Casner	VP Officer	Profile
Baljit Singh	Head Operations	Profile
Howard Doran	Chief Officer	Profile
Salim FCA	Company Secretary	Profile
Fergus Fleming	Chief Officer	Profile
Andria ParksHerrera	VP Marketing	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC